Board of Directors approved the Company’s 2018 individual and consolidated financial statements

Date of occurrence of the event: Mar 8, 2019 Company name: OBI Pharma Inc. Relationship to the Company (please enter “head office” or subsidiaries”): Head office Reciprocal shareholding ratios: N/A Cause of occurrence: From the 2018 Individual/Consolidated Financial Statement: Individual Financial Statement: Operating loss :(1,300,667) thousand dollars Total comprehensive loss for the period :(1,224,428) thousand […]

This article is password protected.

To view the content, please enter your password in the field below